1-4 of 4
Martin A. Graham
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-406: Phase 1 study of the Smac mimetic TL32711 in adult subjects with advanced solid tumors and lymphoma to evaluate safety, pharmacokinetics, pharmacodynamics, and antitumor activity

Ravi K. Amaravadi, Russell J. Schilder, Grace K. Dy, Wen W. Ma, Gerald J. Fetterly, David E. Weng, Martin A. Graham, Jennifer M. Burns, Srinivas K. Chunduru, Stephen M. Condon, Mark A. McKinlay, Alex A. Adjei
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): LB-406.
https://doi.org/10.1158/1538-7445.AM2011-LB-406
Published: 15 April 2011
View article titled, Abstract LB-406: Phase 1 study of the Smac mimetic TL32711 in adult subjects with advanced solid tumors and lymphoma to evaluate safety, pharmacokinetics, pharmacodynamics, and antitumor activity
Journal Articles

Abstract 5274: Noninvasive early assessment of tumor response to the SMAC mimetic TL32711 with a caspase-3/7-specific PET imaging radiotracer

Quang-Dé Nguyen, Graham Smith, Laurence S. Carroll, Martin A. Graham, Eric O. Aboagye
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 5274.
https://doi.org/10.1158/1538-7445.AM2011-5274
Published: 15 April 2011
View article titled, Abstract 5274: Noninvasive early assessment of tumor response to the SMAC mimetic TL32711 with a caspase-3/7-specific PET imaging radiotracer
Journal Articles

Preclinical Evaluation of the Fluorinated 2-Nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) Acetamide (SR-4554) as a Probe for the Measurement of Tumor Hypoxia

Eric O. Aboagye, Ross J. Maxwell, Andrew B. Kelson, Michael Tracy, Alexander D. Lewis, Martin A. Graham, Michael R. Horsman, John R. Griffiths, Paul Workman
Journal: Cancer Research
Cancer Res (1997) 57 (15): 3314–3318.
Published: 01 August 1997
View article titled, Preclinical Evaluation of the Fluorinated 2-Nitroimidazole <em>N</em>-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) Acetamide (SR-4554) as a Probe for the Measurement of Tumor Hypoxia
Open the PDF for Preclinical Evaluation of the Fluorinated 2-Nitroimidazole <em>N</em>-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) Acetamide (SR-4554) as a Probe for the Measurement of Tumor Hypoxia in another window
Journal Articles

Phase I Trial and Pharmacokinetics of Trimelamol (N2,N4,N6-Trihydroxymethyl-N2,N4,N6-trimethylmelamine)

Ian R. Judson, A. Hilary Calvert, Christine J. Rutty, George Abel, Lindsey A. Gumbrell, Martin A. Graham, Barrie D. Evans, Derry E. V. Wilman, Susan E. Ashley, Fiona Cairnduff
Journal: Cancer Research
Cancer Res (1989) 49 (19): 5475–5479.
Published: 01 October 1989
View article titled, Phase I Trial and Pharmacokinetics of Trimelamol (<em>N</em><sup>2</sup>,<em>N</em><sup>4</sup>,<em>N</em><sup>6</sup>-Trihydroxymethyl-<em>N</em><sup>2</sup>,<em>N</em><sup>4</sup>,<em>N</em><sup>6</sup>-trimethylmelamine)
Open the PDF for Phase I Trial and Pharmacokinetics of Trimelamol (<em>N</em><sup>2</sup>,<em>N</em><sup>4</sup>,<em>N</em><sup>6</sup>-Trihydroxymethyl-<em>N</em><sup>2</sup>,<em>N</em><sup>4</sup>,<em>N</em><sup>6</sup>-trimethylmelamine) in another window